Johanna Janke

Title: Johanna Janke: Innovator in Cardio-Protective Pharmaceuticals

Introduction

Johanna Janke is a prominent inventor based in Freiburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compositions aimed at enhancing cardiovascular health. Her work exemplifies the intersection of scientific research and practical application in medicine.

Latest Patents

Johanna Janke holds a patent for a cardio-protective pharmaceutical composition. This composition includes an inert carrier and a pharmaceutically-effective amount of a combination of 2,4,7-triamino-6-phenyl-pteridine (triamterene) and a calcium antagonist, such as α-isopropyl-α-[(N-methyl-N-homoveratryl)-γ-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile-hydrochloride (verapamil). This innovative formulation aims to provide protective benefits for cardiovascular health.

Career Highlights

Johanna Janke is associated with Rohm Pharma GmbH, where she has been instrumental in advancing pharmaceutical research and development. Her expertise in the field has led to the creation of effective therapeutic solutions that address critical health issues.

Collaborations

Throughout her career, Johanna has collaborated with notable professionals, including Albrecht Fleckenstein and Klaus Lossnitzer. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical industry.

Conclusion

Johanna Janke's contributions to the field of cardio-protective pharmaceuticals highlight her role as a leading inventor. Her innovative work continues to impact the medical community positively, paving the way for advancements in cardiovascular treatments.